A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Condition:   Crohn's Disease Interventions:   Drug: Vedolizumab;   Drug: Adalimumab;   Drug: Ustekinumab Sponsor:   Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials